Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Boston Scientific Prices $7.66 Billion in Notes to Fund Penumbra Acquisition

Boston Scientific Prices $7.66 Billion in Notes to Fund Penumbra Acquisition

MT newswireMT newswire2026/11/20 08:03
04:03 AM EST, 11/20/2026 (MT Newswires) -- Boston Scientific (BSX) said Thursday it priced a $3 billion US dollar-denominated notes offering and 4.25 billion euros ($4.66 billion) euro-dominated offering to help finance its planned acquisition of Penumbra. The company said the US offering includes $1 billion of 5.375% senior notes due 2029, $750 million of 5.5% notes due 2031, $750 million of 5.75% notes due 2033 and $500 million of 5.875% notes due 2036. The euro offering includes 500 million euros of floating-rate notes due 2028, 500 million euros of 3.875% notes due 2028, 750 million euros of 4.125% notes due 2030, 750 million euros of 4.5% notes due 2034, 1 billion euros of 4.75% notes due 2038 and 750 million euros of 5.125% notes due 2046, it added. The company said it plans to use the proceeds, along with cash on hand and borrowings, to fund the cash consideration for the Penumbra acquisition and related expenses, adding that any remaining proceeds may be used for general corporate purposes. The offerings are expected to close Dec. 1 and are not conditional on each other or completion of the acquisition, Boston Scientific said. It added if the Penumbra deal is not completed by the applicable deadline, the fixed-rate notes will be subject to mandatory redemption at 101% of principal, plus accrued and unpaid interest.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!